W
JAZZ icon

WealthCollab’s Jazz Pharmaceuticals JAZZ Stock Holding History

WealthCollab’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.6K Hold
69
– – 0.01% 456
2026
Q1 		$13K Hold
69
– – 0.01% 475
2025
Q4 		$11.7K Hold
69
– – ﹤0.01% 522
2025
Q3 		$9.1K Sell
69
-13
-16% -$1.56K ﹤0.01% 542
2025
Q2 		$8.7K Buy
82
+39
+91% +$4.24K ﹤0.01% 528
2025
Q1 		$5.34K Hold
43
– – ﹤0.01% 611
2024
Q4 		$5.3K Hold
43
– – ﹤0.01% 581
2024
Q3 		$4.79K Buy
+43
New +$4.71K ﹤0.01% 621

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

WealthCollab's JAZZ Position: Q2 2026 in Review

WealthCollab held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 69 shares worth $16.6K. The position accounts for 0.01% of the portfolio, ranked #456.

WealthCollab first reported a position in JAZZ in Q3 2024 and has held it in 8 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • WealthCollab held 69 shares of Jazz Pharmaceuticals worth $16.6K as of Q2 2026.
  • WealthCollab left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
  • Jazz Pharmaceuticals made up 0.01% of WealthCollab's portfolio in Q2 2026, its #456 holding.
  • WealthCollab first reported a position in Jazz Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.